Authors:
Paradiso, A
Schittulli, F
Cellamare, G
Mangia, A
Marzullo, F
Lorusso, V
De Lena, M
Citation: A. Paradiso et al., Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negativebreast cancer, J CL ONCOL, 19(19), 2001, pp. 3929-3937
Authors:
Xu, JM
Song, ST
Tang, ZM
Jiang, ZF
Liu, XQ
Zhang, J
Liu, XW
Paradiso, A
Citation: Jm. Xu et al., Neoadjuvant chemotherapy in inoperable, locally advanced, and inflammatorybreast carcinoma - A pilot study of MTT assay in vitro and outcome analysis of 10 patients, AM J CL ONC, 24(3), 2001, pp. 259-263
Authors:
Tommasi, S
Abatangelo, M
Lacalamita, R
Montemurro, S
Marzullo, F
Paradiso, A
Citation: S. Tommasi et al., Mutations spanning P53 exons 5-9 detected by non-isotopic RNAse cleavage assay and protein expression in human colon cancer, CANC GENET, 129(1), 2001, pp. 40-42
Authors:
Paradiso, A
Simone, G
De Lena, M
Leone, B
Vallejo, C
Lacava, J
Dellapasqua, S
Daidone, MG
Costa, A
Citation: A. Paradiso et al., Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer, BR J CANC, 84(5), 2001, pp. 651-658
Authors:
Reshkin, SJ
Bellizzi, A
Albarani, V
Guerra, L
Tommasino, M
Paradiso, A
Casavola, V
Citation: Sj. Reshkin et al., Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na+/H+ exchange, motility, and invasion induced byserum deprivation, J BIOL CHEM, 275(8), 2000, pp. 5361-5369
Authors:
Paradiso, A
Simone, G
Petroni, S
Leone, B
Vallejo, C
Lacava, J
Romero, A
Machiavelli, M
De Lena, M
Allegra, CJ
Johnston, PG
Citation: A. Paradiso et al., Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients, BR J CANC, 82(3), 2000, pp. 560-567
Authors:
Coluccia, M
Nassi, A
Boccarelli, A
Giordano, D
Cardellicchio, N
Intini, FP
Natile, G
Barletta, A
Paradiso, A
Citation: M. Coluccia et al., In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2{E-HN=C(OMe)Me}(2)], INT J ONCOL, 15(5), 1999, pp. 1039-1044
Authors:
Reshkin, SJ
Tedone, T
Correale, M
Mangia, A
Casavola, V
Paradiso, A
Citation: Sj. Reshkin et al., Association of pS2 (TFF1) release with breast tumour proliferative rate: in vitro and in vivo studies, CELL PROLIF, 32(2-3), 1999, pp. 107-118
Authors:
Lorusso, V
Mancarella, S
Catino, A
Brandi, M
Paradiso, A
Latorre, A
Mastria, A
De Mitrio, A
De Lena, M
Citation: V. Lorusso et al., Mitoxantrone, l-leucovorin and 5-fluorouracil: An effective and well tolerated first-line treatment for advanced breast cancer, TUMORI, 85(1), 1999, pp. 60-64
Authors:
Paradiso, A
Tommasi, S
Barletta, A
Leone, B
Lacava, J
Vellejo, C
Labriola, A
Marzullo, F
Altieri, R
Schittulli, F
De Lena, M
Citation: A. Paradiso et al., Metastatic site and p53 primary tumor expression in previously untreated stage IV breast cancer patients, ANTICANC R, 19(5C), 1999, pp. 4523-4528
Authors:
Massari, A
Saladini, L
Sisinni, F
Napolitano, W
Hemmje, M
Paradiso, A
Leissler, M
Citation: A. Massari et al., Virtual Reality systems for browsing multimedia, HANDBOOK OF INTERNET AND MULTIMEDIA SYSTEMS AND APPLICATIONS, 1999, pp. 709-732